UnitedHealth Group reported solid third quarter 2025 results with strong revenue growth, driven by UnitedHealthcare and Optum segments, while raising its full-year earnings outlook. The company is focused on strengthening performance for future growth.
Consolidated revenues grew 12% year-over-year to $113.2 billion.
positiveUnitedHealthcare revenues grew 16% year-over-year to $87.1 billion, serving 50.1 million consumers.
positiveOptum revenues grew 8% year-over-year to $69.2 billion, driven by Optum Rx.
positiveFull year 2025 earnings outlook raised to at least $14.90 per share (GAAP) and $16.25 per share (adjusted).
positiveConsolidated earnings from operations decreased 50% year-over-year to $4.3 billion.
negativeNet margin compressed significantly to 2.1% from 6.0% year-over-year.
negativeUnitedHealthcare's operating margin declined to 2.1% from 5.6% year-over-year, primarily due to elevated medical costs and regulatory impacts.
attentionOptum Health's operating earnings declined significantly, with operating margin at 1% compared to 8.3% year-over-year, due to reimbursement pressure and elevated utilization/costs.
attentionMargin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.
Forward-looking guidance is subject to change and does not constitute a guarantee. Actual results may differ materially from these estimates.
Focused on strengthening performance and positioning for durable and accelerating growth in 2026 and beyond.
Results reflect solid execution toward the company's goals.
Raised 2025 earnings outlook.
Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.
Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.